APMA submitted comments to CMS and Acumen, LLC, pressing for changes to the draft 2027 Diabetic Disease MIPS Value Pathway (MVP) Candidate. While APMA generally supports the development of an additional MVP option, we urged CMS to make substantive changes to ensure the pathway actually reduces burden and allows podiatrists to succeed in MIPS. Specifically, APMA recommended:
Maintain automatic reweighting of the Promoting Interoperability Performance Category for “small practices” and other small practice bonus opportunities
Remove the topped-out status and scoring limitations on all quality measures in the MVP
Add an additional improvement activity option within the Podiatry MVP
Retire the TPCC measure.
Read this and all past comment letters in full at www.apma.org/commentletters. If you have any questions or concerns related to MIPS, please email APMA at MIPS@apma.org.